Personalized approach to the selection of standard and targeted therapies in metastatic colorectal cancer

被引：0
|
作者：
Engel, R. [1 ,2 ]
Boka, H. [2 ]
Archer, S. [5 ]
Nguyen, S. [3 ]
Nickless, D. [4 ]
Niap, A. [4 ]
Plazzer, J. P. [1 ]
Georges, C. [1 ]
Fennell, L. [2 ]
Skinner, L. [2 ]
Mcmurrick, P. [1 ]
Abud, H. [2 ]
机构：
[1] Cabrini Monash Univ, Cabrini Hlth, Dept Surg, Melbourne, Vic, Australia
[2] Monash Biomed Discovery Inst, Dept Anat & Dev Biol, Clayton, Vic, Australia
[3] Cabrini Hosp, IMED Radiol Network, Melbourne, Vic, Australia
[4] Cabrini Hosp, Dept Anat Pathol, Melbourne, Vic, Australia
[5] Monash Univ, Monash Bioinformat Platform, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
326
引用
收藏
页码：32 / 33
页数：2
相关论文
共 50 条
  • [1] Combining chemotherapy and targeted therapies in metastatic colorectal cancer
    J Rodriguez
    R Zarate
    E Bandres
    A Viudez
    A Chopitea
    J García-Foncillas
    I Gil-Bazo
    [J]. World Journal of Gastroenterology, 2007, (44) : 5867 - 5876
  • [2] Combining chemotherapy and targeted therapies in metastatic colorectal cancer
    Rodriguez, J.
    Zarate, R.
    Bandres, E.
    Viudez, A.
    Chopitea, A.
    Garcia-Foncillas, I.
    Gil-Bazo, I.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (44) : 5867 - 5876
  • [3] Addressing Resistance to Targeted Therapies in Metastatic Colorectal Cancer
    Jones, Jeremy C.
    Ciombor, Kristen K.
    Wu, Christina
    Bekaii-Saab, Tanios S.
    Strickler, John
    [J]. ONCOLOGY-NEW YORK, 2021, 35 (10): : 654 - 660
  • [4] Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!
    Moehler, Markus
    Thomaidis, Thomas
    Zeifri, Chourouk
    Barhoom, Tareq
    Marquardt, Jens
    Ploch, Philippe
    Schattenberg, Joern
    Maderer, Annett
    Schimanski, Carl Christoph
    Weinmann, Arndt
    Woerns, Marcus Alexander
    Kranich, Anne L.
    Warnecke, Jens M.
    Galle, Peter Robert
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (03) : 515 - 522
  • [5] Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!
    Markus Moehler
    Thomas Thomaidis
    Chourouk Zeifri
    Tareq Barhoom
    Jens Marquardt
    Philippe Ploch
    Joern Schattenberg
    Annett Maderer
    Carl Christoph Schimanski
    Arndt Weinmann
    Marcus Alexander Woerns
    Anne L. Kranich
    Jens M. Warnecke
    Peter Robert Galle
    [J]. Journal of Cancer Research and Clinical Oncology, 2015, 141 : 515 - 522
  • [6] More is less—combining targeted therapies in metastatic colorectal cancer
    Cornelis J. A. Punt
    Jolien Tol
    [J]. Nature Reviews Clinical Oncology, 2009, 6 : 731 - 733
  • [7] Metastatic colorectal cancer: Is there one standard approach?
    Saltz, Leonard B.
    [J]. ONCOLOGY-NEW YORK, 2005, 19 (09): : 1147 - 1154
  • [8] Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer
    Gonzalez, Nadia Saoudi
    Ros, Javier
    Baraibar, Iosune
    Salva, Francesc
    Rodriguez-Castells, Marta
    Alcaraz, Adriana
    Garcia, Ariadna
    Tabernero, Josep
    Elez, Elena
    [J]. CANCERS, 2024, 16 (02)
  • [9] Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence
    Rico, Gonzalo Tapia
    Townsend, Amanda R.
    Broadbridge, Vy
    Price, Timothy J.
    [J]. DRUGS & AGING, 2017, 34 (03) : 173 - 189
  • [10] Efficacy of Targeted Therapies in Metastatic Colorectal Cancer: Meta-Analysis
    Gouverneur, Amandine
    Arnaud, Mickael
    Berdai, Driss
    DeBoissieu, Paul
    Fourrier-Reglat, Annie
    Noize, Pernelle
    Salvo, Francesco
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 363 - 364
12345